_version_ 1783450902328246272
author Chretien, Anne-Sophie
Fauriat, Cyril
Orlanducci, Florence
Rey, Jerome
Borg, Gaelle Bouvier
Gautherot, Emmanuel
Granjeaud, Samuel
Demerle, Clemence
Hamel, Jean-François
Cerwenka, Adelheid
von Strandmann, Elke Pogge
Ifrah, Norbert
Lacombe, Catherine
Cornillet-Lefebvre, Pascale
Delaunay, Jacques
Toubert, Antoine
Arnoulet, Christine
Vey, Norbert
Olive, Daniel
author_facet Chretien, Anne-Sophie
Fauriat, Cyril
Orlanducci, Florence
Rey, Jerome
Borg, Gaelle Bouvier
Gautherot, Emmanuel
Granjeaud, Samuel
Demerle, Clemence
Hamel, Jean-François
Cerwenka, Adelheid
von Strandmann, Elke Pogge
Ifrah, Norbert
Lacombe, Catherine
Cornillet-Lefebvre, Pascale
Delaunay, Jacques
Toubert, Antoine
Arnoulet, Christine
Vey, Norbert
Olive, Daniel
author_sort Chretien, Anne-Sophie
collection PubMed
description
format Online
Article
Text
id pubmed-6739213
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-67392132019-09-18 Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia Chretien, Anne-Sophie Fauriat, Cyril Orlanducci, Florence Rey, Jerome Borg, Gaelle Bouvier Gautherot, Emmanuel Granjeaud, Samuel Demerle, Clemence Hamel, Jean-François Cerwenka, Adelheid von Strandmann, Elke Pogge Ifrah, Norbert Lacombe, Catherine Cornillet-Lefebvre, Pascale Delaunay, Jacques Toubert, Antoine Arnoulet, Christine Vey, Norbert Olive, Daniel Oncotarget Correction Impact Journals LLC 2019-09-10 /pmc/articles/PMC6739213/ /pubmed/31534634 http://dx.doi.org/10.18632/oncotarget.27198 Text en Copyright: © 2019 Chretien et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Chretien, Anne-Sophie
Fauriat, Cyril
Orlanducci, Florence
Rey, Jerome
Borg, Gaelle Bouvier
Gautherot, Emmanuel
Granjeaud, Samuel
Demerle, Clemence
Hamel, Jean-François
Cerwenka, Adelheid
von Strandmann, Elke Pogge
Ifrah, Norbert
Lacombe, Catherine
Cornillet-Lefebvre, Pascale
Delaunay, Jacques
Toubert, Antoine
Arnoulet, Christine
Vey, Norbert
Olive, Daniel
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
title Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
title_full Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
title_fullStr Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
title_full_unstemmed Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
title_short Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
title_sort correction: nkp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739213/
https://www.ncbi.nlm.nih.gov/pubmed/31534634
http://dx.doi.org/10.18632/oncotarget.27198
work_keys_str_mv AT chretienannesophie correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT fauriatcyril correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT orlanducciflorence correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT reyjerome correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT borggaellebouvier correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT gautherotemmanuel correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT granjeaudsamuel correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT demerleclemence correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT hameljeanfrancois correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT cerwenkaadelheid correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT vonstrandmannelkepogge correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT ifrahnorbert correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT lacombecatherine correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT cornilletlefebvrepascale correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT delaunayjacques correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT toubertantoine correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT arnouletchristine correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT veynorbert correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia
AT olivedaniel correctionnkp30expressionisaprognosticimmunebiomarkerforstratificationofpatientswithintermediateriskacutemyeloidleukemia